Patents by Inventor Kyle Seifert

Kyle Seifert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10912830
    Abstract: The inventive subject matter relates to novel antibodies to lacritin splice variants, improved methods for detecting lacritin splice variants, and methods for diagnosing Sjögren's Syndrome.
    Type: Grant
    Filed: February 1, 2018
    Date of Patent: February 9, 2021
    Assignee: JAMES MADISON INNOVATIONS, INC.
    Inventors: Robert L McKown, Kyle Seifert, Ronald W Raab
  • Patent number: 10905118
    Abstract: The inventive subject matter relates to compounds of Formula I and Formula II, compositions thereof, and processes for making such compounds as presently claimed and further described herein. The inventive compounds and compositions have antimicrobial properties and are useful as environmental disinfectants, topical cleansers such as topical personal care compositions, sanitizers, preservatives, in water treatment, as permanent or erodible coatings for medical devices and appliances, and in therapeutics.
    Type: Grant
    Filed: October 24, 2015
    Date of Patent: February 2, 2021
    Assignee: JAMES MADISON INNOVATIONS, INC.
    Inventors: Kevin L. Caran, Kyle Seifert
  • Publication number: 20180214545
    Abstract: The inventive subject matter relates to novel antibodies to lacritin splice variants, improved methods for detecting lacritin splice variants, and methods for diagnosing Sjögren's Syndrome.
    Type: Application
    Filed: February 1, 2018
    Publication date: August 2, 2018
    Inventors: Robert L. McKown, Kyle Seifert, Ronald W. Raab
  • Publication number: 20170135342
    Abstract: The inventive subject matter relates to compounds of Formula I and Formula II, compositions thereof, and processes for making such compounds as presently claimed and further described herein. The inventive compounds and compositions have antimicrobial properties and are useful as environmental disinfectants, topical cleansers such as topical personal care compositions, sanitizers, preservatives, in water treatment, as permanent or erodible coatings for medical devices and appliances, and in therapeutics.
    Type: Application
    Filed: October 24, 2015
    Publication date: May 18, 2017
    Inventors: Kevin L. Caran, Kyle Seifert
  • Publication number: 20170029363
    Abstract: The inventive subject matter relates to compounds of Formula I, compositions thereof, and processes for making such compounds as further described herein. The inventive compounds and compositions have antimicrobial properties and are useful as environmental disinfectants, topical cleansers such as topical personal care compositions, sanitizers, preservatives, in water treatment, as permanent or erodible coatings for medical devices and appliances, and in therapeutics. Additionally, the compounds of Formula I will serve as synthetic intermediates for making additional novel derivatives of triscationic amphiphile compounds.
    Type: Application
    Filed: August 1, 2016
    Publication date: February 2, 2017
    Inventors: Kevin L. Caran, Kyle Seifert
  • Patent number: 9556109
    Abstract: The inventive subject matter relates to compounds of Formula I, compositions thereof, and processes for making such compounds as further described herein. The inventive compounds and compositions have antimicrobial properties and are useful as environmental disinfectants, topical cleansers such as topical personal care compositions, sanitizers, preservatives, in water treatment, as permanent or erodible coatings for medical devices and appliances, and in therapeutics. Additionally, the compounds of Formula I will serve as synthetic intermediates for making additional novel derivatives of triscationic amphiphile compounds.
    Type: Grant
    Filed: August 1, 2016
    Date of Patent: January 31, 2017
    Assignee: JAMES MADISON INNOVATIONS, INC.
    Inventors: Kevin L. Caran, Kyle Seifert
  • Publication number: 20080039386
    Abstract: The present invention provides a group B streptococcal (GBS) surface antigen, designated epsilon antigen, that is co-expressed with the delta antigen on a subset of serotype III GBS. Epsilon is expressed on more pathogenic Restriction Digest Pattern (RDP) III-3 GBS, but not on RDP types 1, 2, or 4. Accordingly, the present invention provides compositions and methods for detecting a group B streptococcus serotype III, RDP III-3 strain. Vaccines and methods of identifying agents which inhibit adhesion of a group B streptococcal cell to a host cell are also provided.
    Type: Application
    Filed: August 19, 2005
    Publication date: February 14, 2008
    Inventors: Linda Brady, Kyle Seifert, Elisabeth Adderson, John Bohnsack